propofol has been researched along with Hemorrhage, Uterine in 4 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective randomised study 52 ASA I patients scheduled for ambulatory pregnancy termination were premedicated with lorazepam and received alfentanil prior to anaesthesia induction with propofol (group P, n = 26) or with sevoflurane 8% (group S, n = 26) using the single breath vital capacity technique." | 5.08 | Comparison of sevoflurane and propofol for ambulatory anaesthesia in gynaecological surgery. ( Feiss, P; Lahrimi, A; Nathan, N; Peyclit, A, 1998) |
| "Operating conditions, recovery and postoperative nausea and vomiting (PONV) were assessed." | 2.69 | Comparison of sevoflurane-nitrous oxide and propofol-alfentanil-nitrous oxide anaesthesia for minor gynaecological surgery. ( Korttila, K; Nelskylä, K; Yli-Hankala, A, 1999) |
| "Although peripartum cardiac arrest is rare, the prognosis of the event may be worse than in nonpregnant patients because the events is often associated with pulmonary or amniotic embolisms." | 1.31 | [A case of cardiac arrest at induction of anesthesia for postpartum hysterectomy]. ( Amano, K; Hashiba, M; Hoka, S; Okamoto, H; Okutomi, T; Saito, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tas, A | 1 |
| Mıstanoglu, V | 1 |
| Darcın, S | 1 |
| Kececioglu, M | 1 |
| Hashiba, M | 1 |
| Okutomi, T | 1 |
| Saito, K | 1 |
| Amano, K | 1 |
| Okamoto, H | 1 |
| Hoka, S | 1 |
| Nathan, N | 1 |
| Peyclit, A | 1 |
| Lahrimi, A | 1 |
| Feiss, P | 1 |
| Nelskylä, K | 1 |
| Korttila, K | 1 |
| Yli-Hankala, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures: Does it Increase Blood Loss and Interventions for Blood Loss and Why Do Anesthesiologists Choose to Use It?[NCT01048658] | Phase 4 | 160 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01048658)
Timeframe: Post-procedure, within 30 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Sevoflurane | 13 |
| No Sevoflurane | 11 |
Provider report for need to intervene due to blood loss (yes/no) (NCT01048658)
Timeframe: At time of uterine evacuation and immediately post-operatively, an average of 7.1 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Sevoflurane | 20 |
| No Sevoflurane | 13 |
Procedural blood loss greater than 300 mL. Blood loss was measured in a standardized fashion (amniotic fluid was discarded, blood was separated from tissue, and all gauze surgical drapes weighed). (NCT01048658)
Timeframe: At time of uterine evacuation, an average of 7.1 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| Sevoflurane | 12 |
| No Sevoflurane | 6 |
Length of procedure from time of speculum placement to time of speculum removal, in minutes. (NCT01048658)
Timeframe: Time of speculum place to time of speculum removal, an average of 7.1 minutes
| Intervention | minutes (Mean) |
|---|---|
| Sevoflurane | 7.0 |
| No Sevoflurane | 7.3 |
Scores reported on 10-cm Visual Analog Scale (VAS anchors: 0= not satisfied at all, 10= completely satisfied) . Reported as mean +/- standard deviation. Subjects and providers were blinded to anesthesia method. Subjects and providers completed post-operative questionnaire within 30 minutes of procedure completion. (NCT01048658)
Timeframe: Post-procedure, within 30 minutes
| Intervention | cm (Mean) | |
|---|---|---|
| Provider Satisfaction | Patient Satisfaction | |
| No Sevoflurane | 9.3 | 8.2 |
| Sevoflurane | 9.4 | 8.4 |
3 trials available for propofol and Hemorrhage, Uterine
| Article | Year |
|---|---|
Tramadol versus fentanyl during propofol-based deep sedation for uterine dilatation and curettage: a prospective study.
Topics: Adult; Analgesics, Opioid; Deep Sedation; Dilatation and Curettage; Double-Blind Method; Female; Fen | 2014 |
Comparison of sevoflurane and propofol for ambulatory anaesthesia in gynaecological surgery.
Topics: Abortion, Induced; Activities of Daily Living; Adult; Ambulatory Surgical Procedures; Anesthesia, Ge | 1998 |
Comparison of sevoflurane-nitrous oxide and propofol-alfentanil-nitrous oxide anaesthesia for minor gynaecological surgery.
Topics: Adult; Alfentanil; Anesthesia Recovery Period; Anesthetics, Combined; Anesthetics, Inhalation; Anest | 1999 |
1 other study available for propofol and Hemorrhage, Uterine
| Article | Year |
|---|---|
[A case of cardiac arrest at induction of anesthesia for postpartum hysterectomy].
Topics: Adult; Anesthesia, General; Cesarean Section; Female; Heart Arrest; Humans; Hysterectomy; Intraopera | 2002 |